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Carotid Artery Stenting*
Peter A. McCullough, MD, MPH, Allan Young, DO, William P. Shutze, MDP ercutaneous carotid artery stenting for sig-niﬁcant stenoses has considerably advancedover the years with improved catheters,
guidewires, and embolic protection devices. How-
ever, the aorta from the bifurcation to the carotids
is crossed with wires and catheter exchanges, and
the vessels are imaged with iodinated contrast that
has both a hemodynamic/ischemic and ischemic
mechanism of injury to the renal tubular cells,
mainly in the outer medulla. Contemporary out-
comes reported for 985,737 consecutive patients
undergoing percutaneous coronary intervention
(PCI) at 1,253 sites participating in the National
Cardiovascular Data Registry (NCDR) Cath-PCI regis-
try highlighted an overall rate of contrast-induced
acute kidney injury (CI-AKI) of 7.1% (1). Although
much has been published concerning the epidemi-
ology of CI-AKI in the setting of percutaneous coro-
nary intervention (PCI), little is known about the
risks of CI-AKI in patients undergoing carotid artery
stenting (2,3).SEE PAGE 1506In this issue of JACC: Cardiovascular Inter-
ventions, Donahue et al. (4) report on 126 patients
with pre-existing chronic kidney disease (CKD) who
underwent carotid artery stenting at a mean age of
w76 years with an estimated glomerular ﬁltration
rate of w42 ml/min/1.73 m2 receiving a contrast load*Editorials published in JACC: Cardiovascular Interventions reﬂect the
views of the authors and do not necessarily represent the views
of JACC: Cardiovascular Interventions or the American College of
Cardiology.
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paper to disclose.of 121 ml. The rate of CI-AKI of 17% was more than
double that of patients undergoing PCI (1,5). The
ﬁnding of intraprocedural hypotension as a major
determinant of CI-AKI during carotid artery stenting
is novel and suggests transient well-documented
decreases in systolic blood pressure (<90 mm Hg)
or bradycardia (<60 beats/min) have an additive
impact on CI-AKI in addition to the relatively
modest contrast volumes used in this series. Both
hemodynamic instability and CI-AKI were indepen-
dent predictors of clinical outcomes at 30 days with
large measures of association, suggesting that even
more detailed accounting of confounders would not
adjust away these relationships.
Approximately two-thirds of those who became
hemodynamically unstable needed intravenous va-
sopressors. Hypotension and bradycardia appeared
to be more likely in cases in which there was
balloon pre-dilation. The number of catheter ex-
changes was not reported, and it is unclear whether
there were any procedural factors that could have
caused cholesterol microembolism to the kidneys.
Because the contrast volumes were relatively low
and were not signiﬁcant predictors of CI-AKI,
hemodynamic and other mechanisms appear to
be more important in this procedure compared
with PCI.
Avoidance of bradycardia and hypotension is
an important part of the management of patients
during carotid artery stenting (Figure 1). The key
steps in practice include pre-treatment with atropine
and cessation of antihypertensive drugs and phos-
phodiesterase inhibitors on the day of the proce-
dure. To anticipate the possibility of hypotension or
bradycardia, intravenous dopamine should be pre-
pared and ready for infusion, and isoproterenol
should be available for bradycardia that occurs
despite anticholinergic pre-medication. If hypoten-
sion occurs, gentle volume administration can also
FIGURE 1 The Pathophysiology of CI-AKI in the Setting of Carotid Stenting Involves Both Transient Hemodynamic and Chemotoxic Injury to the Kidneys
Potential mechanisms contributing to contrast-induced acute kidney injury in patients undergoing carotid artery stenting. cns ¼ central nervous system; la ¼ left atrium;
lv ¼ left ventricle; ra ¼ right atrium; rv ¼ right ventricle; SA ¼ sinoatrial.
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1516be used with care not to overhydrate, which can lead
to bladder distention and reﬂex vagal stimulation.
In the future, it is possible that newer vascular
interventional techniques or the use of novel vaso-
pressor support may lessen the frequency of brady-
cardia and hypotension and translate into a reduced
risk of CI-AKI. Additionally, because CI-AKI during
carotid artery stenting appears to be ampliﬁed by
hemodynamic instability, it could conceivably be
ameliorated by remote ischemic pre-conditioning
using transient arm ischemia with a blood pressure
cuff, as recently reported in several trials (6,7). As
in studies of PCI, it is most desirable to avoid CI-
AKI after carotid artery stenting to be at thelowest risk of associated clinical complications in
the short and intermediate term.
In summary, it appears that CI-AKI is more com-
mon after carotid artery stenting than PCI and that
the unique risk feature is intraprocedural hypoten-
sion. More research is needed on the potential
vascular-renal mechanisms of injury at play in this
patient population brought to light by the present
study.
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